Related Experiment Video
Updated: Jul 13, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative
Michael D Stein1, Pamela Dubyak, Deb Herman
1Department of Medicine, Division of General Internal Medicine, Rhode Island Hospital, Providence, Rhode Island 02903, USA. mstein@lifespan.org
Abstract:
Fifty-nine hepatitis C (HCV) seronegative drug injectors (IDUs) were interviewed regarding their injection equipment sharing behaviors. Participants were 75% male, 66% Caucasian, had injected an average of nine years, and were very knowledgeable about HCV transmission risk. One-third used needles or works after another injector within the past six months. Lower perceived personal risk and lower perceived availability of clean needles were significantly associated with sharing. Injectors were more likely to share when emotionally upset or experiencing withdrawal symptoms. Despite, or perhaps because of, their HCV seronegative status, IDUs continue to share. Tailoring messages to modifiable perceptions of risk may be useful in reducing continued drug equipment sharing.
Related Concept Videos
Hepatitis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Viral Hepatitis I: Introduction
Prevention of Further Absorption of Poison
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test